Informed-money record
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
0
Bearish filings
500
Named actors
16
Disclosed $ (bull / bear)
$0 / $28.9M
| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-07-07 | Director EVNIN LUKE | sold | $33K | SEC ↗ |
| 2026-07-06 | Director EVNIN LUKE | sold | $11K | SEC ↗ |
| 2026-07-06 | Shareholder (via Merrill Lynch) MPM BioVentures 2014, L.P. | filed notice to sell | $33K | SEC ↗ |
| 2026-07-06 | Shareholder (via Merrill Lynch) MPM BioVentures 2014 (B), L.P. | filed notice to sell | $2K | SEC ↗ |
| 2026-07-06 | Shareholder (via Merrill Lynch) UBS Oncology Impact Fund, L.P. | filed notice to sell | $27K | SEC ↗ |
475+ more disclosures in the window — the full record, scoring, and validation are for members.
Want the read, not just the record?
Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.
Create a free account →Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only — a dense name; figures cover the most recent 500. Descriptive, not investment advice. Methodology · Today's notable signals
| 2026-07-06 | Shareholder (via Merrill Lynch) MPM Asset Management LLC | filed notice to sell | $5K | SEC ↗ |
| 2026-07-06 | Shareholder (via Merrill Lynch) MPM Asset Management Investors BV2014 LLC | filed notice to sell | $1K | SEC ↗ |
| 2026-07-06 | Shareholder (via Merrill Lynch) MPM Oncology Innovations Fund, L.P. | filed notice to sell | $7K | SEC ↗ |
| 2026-06-29 | Director EVNIN LUKE | sold | $47K | SEC ↗ |
| 2026-06-29 | Shareholder (via Merrill Lynch) MPM BioVentures 2014, L.P. | filed notice to sell | $34K | SEC ↗ |
| 2026-06-29 | Shareholder (via Merrill Lynch) MPM BioVentures 2014 (B), L.P. | filed notice to sell | $2K | SEC ↗ |
| 2026-06-29 | Shareholder (via Merrill Lynch) UBS Oncology Impact Fund, L.P. | filed notice to sell | $28K | SEC ↗ |
| 2026-06-29 | Shareholder (via Merrill Lynch) MPM Asset Management LLC | filed notice to sell | $5K | SEC ↗ |
| 2026-06-29 | Shareholder (via Merrill Lynch) MPM Asset Management Investors BV2014 LLC | filed notice to sell | $1K | SEC ↗ |
| 2026-06-29 | Shareholder (via Merrill Lynch) MPM Oncology Innovations Fund, L.P. | filed notice to sell | $8K | SEC ↗ |
| 2026-06-17 | 10% owner / other RA CAPITAL MANAGEMENT, L.P. | sold | $136K | SEC ↗ |
| 2026-06-17 | 10% owner / other RA CAPITAL MANAGEMENT, L.P. | sold | $10K | SEC ↗ |
| 2026-06-16 | 10% owner / other RA CAPITAL MANAGEMENT, L.P. | sold | $52K | SEC ↗ |
| 2026-06-16 | 10% owner / other RA CAPITAL MANAGEMENT, L.P. | sold | $4K | SEC ↗ |
| 2026-06-15 | 10% owner / other RA CAPITAL MANAGEMENT, L.P. | sold | $47K | SEC ↗ |
| 2026-06-15 | 10% owner / other RA CAPITAL MANAGEMENT, L.P. | sold | $3K | SEC ↗ |
| 2026-06-12 | 10% owner / other RA CAPITAL MANAGEMENT, L.P. | sold | $64K | SEC ↗ |
| 2026-06-12 | 10% owner / other RA CAPITAL MANAGEMENT, L.P. | sold | $5K | SEC ↗ |
| 2026-06-11 | 10% owner / other RA CAPITAL MANAGEMENT, L.P. | sold | $93K | SEC ↗ |
| 2026-06-11 | 10% owner / other RA CAPITAL MANAGEMENT, L.P. | sold | $7K | SEC ↗ |